These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26828096)

  • 1. The Transmembrane Domain of HIV-1 gp41 Inhibits T-Cell Activation by Targeting Multiple T-Cell Receptor Complex Components through Its GxxxG Motif.
    Rotem E; Reuven EM; Klug YA; Shai Y
    Biochemistry; 2016 Feb; 55(7):1049-57. PubMed ID: 26828096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation.
    Cohen T; Cohen SJ; Antonovsky N; Cohen IR; Shai Y
    PLoS Pathog; 2010 Sep; 6(9):e1001085. PubMed ID: 20824090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A GxxxG-like motif within HIV-1 fusion peptide is critical to its immunosuppressant activity, structure, and interaction with the transmembrane domain of the T-cell receptor.
    Faingold O; Cohen T; Shai Y
    J Biol Chem; 2012 Sep; 287(40):33503-11. PubMed ID: 22872636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor.
    Cohen T; Pevsner-Fischer M; Cohen N; Cohen IR; Shai Y
    Biochemistry; 2008 Apr; 47(16):4826-33. PubMed ID: 18376816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV gp41 Fusion Protein Inhibits T-Cell Activation through the Lentiviral Lytic Peptide 2 Motif.
    Klug YA; Schwarzer R; Rotem E; Charni M; Nudelman A; Gramatica A; Zarmi B; Rotter V; Shai Y
    Biochemistry; 2019 Feb; 58(6):818-832. PubMed ID: 30602116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 fusion protein exerts complex immunosuppressive effects.
    Ashkenazi A; Faingold O; Shai Y
    Trends Biochem Sci; 2013 Jul; 38(7):345-9. PubMed ID: 23685134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif.
    Bloch I; Quintana FJ; Gerber D; Cohen T; Cohen IR; Shai Y
    FASEB J; 2007 Feb; 21(2):393-401. PubMed ID: 17185749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action.
    Faingold O; Ashkenazi A; Kaushansky N; Ben-Nun A; Shai Y
    J Biol Chem; 2013 Nov; 288(46):32852-60. PubMed ID: 24078631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 gp41 transmembrane domain interacts with the fusion peptide: implication in lipid mixing and inhibition of virus-cell fusion.
    Reuven EM; Dadon Y; Viard M; Manukovsky N; Blumenthal R; Shai Y
    Biochemistry; 2012 Apr; 51(13):2867-78. PubMed ID: 22413880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gp41 dynamically interacts with the TCR in the immune synapse and promotes early T cell activation.
    Yakovian O; Schwarzer R; Sajman J; Neve-Oz Y; Razvag Y; Herrmann A; Sherman E
    Sci Rep; 2018 Jun; 8(1):9747. PubMed ID: 29950577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV gp41 pocket binding domain enables C-terminal heptad repeat transition from mediating membrane fusion to immune modulation.
    Klug YA; Kapach G; Rotem E; Dubreuil B; Shai Y
    Biochem J; 2016 Apr; 473(7):911-8. PubMed ID: 26823547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HIV-1 envelope transmembrane domain binds TLR2 through a distinct dimerization motif and inhibits TLR2-mediated responses.
    Reuven EM; Ali M; Rotem E; Schwarzer R; Gramatica A; Futerman AH; Shai Y
    PLoS Pathog; 2014 Aug; 10(8):e1004248. PubMed ID: 25121610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Env gp41 Transmembrane Domain Dynamics Are Modulated by Lipid, Water, and Ion Interactions.
    Hollingsworth LR; Lemkul JA; Bevan DR; Brown AM
    Biophys J; 2018 Jul; 115(1):84-94. PubMed ID: 29972814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.
    Quintana FJ; Gerber D; Kent SC; Cohen IR; Shai Y
    J Clin Invest; 2005 Aug; 115(8):2149-58. PubMed ID: 16007266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J; Norley S; Kurth R
    AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41.
    Ruegg CL; Strand M
    J Immunol; 1990 May; 144(10):3928-35. PubMed ID: 2139676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx.
    Ruegg CL; Strand M
    Cell Immunol; 1991 Oct; 137(1):1-13. PubMed ID: 1832084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein interactions of the immunoglobulin receptor family tyrosine-based activation motifs present in the T cell receptor zeta subunits and the CD3 gamma, delta and epsilon chains.
    Osman N; Turner H; Lucas S; Reif K; Cantrell DA
    Eur J Immunol; 1996 May; 26(5):1063-8. PubMed ID: 8647168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD3 gamma epsilon/delta epsilon signaling module provides normal T cell functions in the absence of the TCR zeta immunoreceptor tyrosine-based activation motifs.
    Pitcher LA; Mathis MA; Young JA; DeFord LM; Purtic B; Wulfing C; van Oers NS
    Eur J Immunol; 2005 Dec; 35(12):3643-54. PubMed ID: 16259006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein.
    Miyauchi K; Curran AR; Long Y; Kondo N; Iwamoto A; Engelman DM; Matsuda Z
    Retrovirology; 2010 Nov; 7():95. PubMed ID: 21073746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.